Pharmacokinetics of asparaginase in patients with acute lymphoblastic leukemia: prospective observational study.

Pharmacokinetics of asparaginase in patients with acute lymphoblastic leukemia: prospective observational study. - JCCG ALL-ASP19

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040630

Enrollment

110

Registered

2020-06-02

Start date

2020-05-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lymphoblastic leukemia (ALL)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Newly diagnosed acute lymphoblastic leukemia 2) Registered to JPLSG CHM-14 study 3) Age below 40 years old 4) informed consent from patients or guardians

Exclusion criteria

Exclusion criteria: Judged to be inappropriate for registration by investigators

Design outcomes

Primary

Measure	Time frame
The incidence of silent inactivation of asparaginase in patients with ALL.	—

Countries

Japan

Contacts

Public Contacthidemi SHIMONODAN

Miyazaki Prefectual Miyazaki Hospital Division of Pediatrics

all-asp19@pref-hp.miyazaki.miyazaki.jp0985-24-4181

Outcome results